Clinical Trials Logo

Clinical Trial Summary

There are few randomized clinical trials in advanced HIV patients. This is a multicenter, randomized, open clinical trial, comparing 2 parallel groups, to compare the immunological reconstitution and the virological efficacy and safety of 2 different combinations of antiretroviral therapy given once a day (QD): abacavir plus lamivudine plus either dolutegravir, or darunavir-ritonavir during 96 weeks in advanced antiretroviral naïve HIV-1 infected patients with less than 100 CD4+ T-cells/mm3. Primary endpoint is the median increase in CD4+ T-cell count at 48 weeks after starting HAART.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02337322
Study type Interventional
Source Hospital Clinic of Barcelona
Contact
Status Active, not recruiting
Phase Phase 4
Start date March 31, 2015
Completion date December 2019

See also
  Status Clinical Trial Phase
Recruiting NCT02266992 - Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study Phase 2
Recruiting NCT00974285 - Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients N/A
Recruiting NCT00974454 - Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART) N/A
Recruiting NCT00974519 - The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients N/A
Recruiting NCT02542020 - Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis
Completed NCT01766076 - Atorvastatin for HAART Suboptimal Responders Phase 3
Completed NCT01976715 - Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy
Completed NCT01840722 - Brief Intervention for Rural Women at High Risk for HIV/HCV N/A